You are here » Home » Companies » Company Overview » Anuh Pharma Ltd

Anuh Pharma Ltd.

BSE: 506260	Sector: Health care
NSE: N.A.	ISIN Code: INE489G01022

BSE 10:20 | 28 Jan

125.50

-0.90
(-0.71%)

OPEN

125.25

HIGH

126.90

LOW

124.30

NSE 05:30 | 01 Jan

Anuh Pharma Ltd

Add to Watchlist | Add to Portfolio

OPEN	125.25
PREVIOUS CLOSE	126.40
VOLUME	5203
52-Week high	218.70
52-Week low	48.70
P/E	21.86
Mkt Cap.(Rs cr)	629
Buy Price	125.50
Buy Qty	37.00
Sell Price	125.55
Sell Qty	225.00

OPEN	125.25
CLOSE	126.40
VOLUME	5203
52-Week high	218.70
52-Week low	48.70
P/E	21.86
Mkt Cap.(Rs cr)	629
Buy Price	125.50
Buy Qty	37.00
Sell Price	125.55
Sell Qty	225.00

Click here for interactive graph

Anuh Pharma Ltd. (ANUHPHARMA) - News Sector

Dr Reddy's Labs terminates Kuwait-based Covid-19 treatment study

5.58 pm | 27 Jan 2021 | Press Trust of India

Dr Reddy's Laboratories on Wednesday announced termination of Avigan trial study being conducted in Kuwait
Stock calls by Nilesh Jain of Anand Rathi: Buy Pidilite, Godrej Industries

8.45 am | 27 Jan 2021 | Business Standard

Pidilite's stock is in a secular uptrend and has formed a bullish Harami candlestick pattern on the daily chart
Pfizer wants India to order Covid-19 vaccine before pursuing nod

12.06 am | 26 Jan 2021 | Reuters

Pfizer says its application is supported by data from a global study that shows an overall efficacy rate of 95% with no vaccine-related, serious safet...
Dr Reddy's, Zuventus get nod to conduct Covid-19 trials on repurposed drugs

11.58 pm | 25 Jan 2021 | Business Standard

NeuroRx and Relief Therapeutics have partnered to develop a drug called RLF-100 that has anti-inflammatory and anti-cytokine activity properties.
Apollo Hospitals gains 4%, hits new high on successful fund raising via QIP

1.59 pm | 25 Jan 2021 | Business Standard

Apollo Hospitals said it will use the funds raised to acquire a 50 per cent stake in a joint venture, seek inorganic growth opportunities, as well as,...
Aurobindo gains 5% on govt nod for promotion of manufacturing bulk drugs

10.46 am | 25 Jan 2021 | Business Standard

Aurobindo Pharma (through Lyfius Pharma) has received government approval for setting up plants for production of Penicillin-G and 7-ACA, under the PL...
Biocon stock slides on poor Q3 results, exit of biologics arm's MD

12.44 am | 23 Jan 2021 | Business Standard

From its previous close of Rs 441.95 apiece on Thursday, the stock closed 10.89 per cent or Rs 48.15 lower at Rs 393.80, on Friday
Market reacts negatively to Biocon's weaker results, exit of biologics' MD

1.15 pm | 22 Jan 2021 | Business Standard

Analysts have raised doubts over the $1 billion guidance for biosimilars by FY22 and Hamacher's exit due to "professional differences"
SBI, ITC, Titan: Over 50% of Sensex constituents look weak on charts

12.57 pm | 22 Jan 2021 | Business Standard

Technical indicators show that Bharti Airtel, Sun Pharmaceutical Industries, and ONGC are not showing an optimistic view from a short-term perspective
SBI, ITC, Titan: Over 50% of Sensex constituents look weak on charts

12.57 pm | 22 Jan 2021 | Business Standard

Technical indicators show that Bharti Airtel, Sun Pharmaceutical Industries, and ONGC are not showing an optimistic view from a short-term perspective
Biocon tanks 10% on lower-than-expected December quarter results

10.26 am | 22 Jan 2021 | Business Standard

Due to professional differences with the chairperson on strategic priorities and the vision for the company, Dr Christiane Hamacher has stepped down a...
Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

1.00 am | 22 Jan 2021 | Business Standard

Biocon's consolidated revenue for Q3 of FY21 increased by 7.20 per cent at Rs 1878.9 crore as against Rs 1752.6 crore for the said quarter last year
Alembic Pharma extends decline on mixed December quarter results

10.25 am | 20 Jan 2021 | Business Standard

Motilal Oswal Securities said Alembic Pharma missed Q3FY21 earnings estimate, weighed by lower-than-expected sales in the US
Apollo Hospitals hits record high on launch of Rs 1,000-crore QIP

3.14 pm | 19 Jan 2021 | Business Standard

The final issue price, including any discount to the floor price, will be determined in the fund-raising committee meeting on January 22, 2021
Piramal Enterprises: DHFL acquisition fast-forwards retail aspiration

11.36 pm | 18 Jan 2021 | Business Standard

Integration may take about six months, though execution may be a tightrope walk
New product launches to drive growth for Lupin, US business a key trigger

9.36 pm | 18 Jan 2021 | Business Standard

This should reverse the US underperformance in FY15-20 with margins too moving up sharply
Apollo Hospitals opens QIP with floor price of Rs 2,508.58 a share

8.11 pm | 18 Jan 2021 | Business Standard

Sources said that the hospital chain is targeting large Domestic Mutual Funds, Sovereign Funds
Metropolis Healthcare to acquire Chennai-based diagnostic lab for Rs 511 cr

9.31 am | 18 Jan 2021 | Business Standard

Metropolis will acquire 100 per cent equity of Dr Ganesan's Hitech Diagnostic Centre in a cash and stock deal
Stocks to watch: HDFC Bank, Metropolis Healthcare, Wipro, Airtel, DHFL

8.48 am | 18 Jan 2021 | Business Standard

Metropolis Healthcare said it will acquire Dr Ganesan's Hitech Diagnostic Centre
Here is a derivative strategy for Cadila Health by Vinay Rajani of HDFC Sec

7.22 am | 15 Jan 2021 | Business Standard

The stock price of Cadila Healthcare has broken out from the consolidation which held for last three weeks